(NASDAQ: STIM) Neuronetics's forecast annual revenue growth rate of 9.85% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.27%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.04%.
Neuronetics's revenue in 2026 is $151,636,000.On average, 5 Wall Street analysts forecast STIM's revenue for 2026 to be $11,432,586,234, with the lowest STIM revenue forecast at $10,897,455,744, and the highest STIM revenue forecast at $11,909,958,816. On average, 5 Wall Street analysts forecast STIM's revenue for 2027 to be $12,627,409,446, with the lowest STIM revenue forecast at $11,736,685,094, and the highest STIM revenue forecast at $13,298,236,224.
In 2028, STIM is forecast to generate $14,040,042,598 in revenue, with the lowest revenue forecast at $13,488,906,906 and the highest revenue forecast at $14,452,698,490.